Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Andrew Seaman

Biographic Data

ID7449652
NAMEAndrew Seaman
GIVEN NAMESAndrew
FAMILY NAMESeaman
SIGNATURESEAMAN A
AFFILIATIONSOregon Health & Science University
ORCID0000-0002-8955-6210
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities

    Open Access•A T Estadt, William C Miller et al.•ARTICLE•International Journal of Drug…•2025

    HCV antibody positivity, indicating prior exposure, was highest among those who had recently injected opioids, alone or with stimulants. Additional nucleic acid testing is necessary to confirm active infection. More research is needed to determine the underlying causes of HCV antibody positivity by injection use

  • Harm Reduction and Adaptations Among PWUD in Rural Oregon During Covid-19

    Open Access•Andrew Seaman, Gillian Leichtling et al.•ARTICLE•AIDS and Behavior•2021

  • Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs

    Open Access•Ximena A Levander, Taylor A Vega et al.•ARTICLE•International Journal of Drug…•2021

  • A hepatitis C elimination model in healthcare for the homeless organization

    Open Access•Andrew Seaman, Caroline King et al.•ARTICLE•International Journal of Drug…•2021

  • Life projects

    Open Access•Beth E Williams, Devynne Nelons et al.•ARTICLE•International Journal of Drug…•2019

No prominent works on this page.

  • Life projects

    Open Access•Beth E Williams, Devynne Nelons et al.•ARTICLE•International Journal of Drug…•2019

  • Harm Reduction and Adaptations Among PWUD in Rural Oregon During Covid-19

    Open Access•Andrew Seaman, Gillian Leichtling et al.•ARTICLE•AIDS and Behavior•2021

  • Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs

    Open Access•Ximena A Levander, Taylor A Vega et al.•ARTICLE•International Journal of Drug…•2021

  • A hepatitis C elimination model in healthcare for the homeless organization

    Open Access•Andrew Seaman, Caroline King et al.•ARTICLE•International Journal of Drug…•2021

  • Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities

    Open Access•A T Estadt, William C Miller et al.•ARTICLE•International Journal of Drug…•2025

    HCV antibody positivity, indicating prior exposure, was highest among those who had recently injected opioids, alone or with stimulants. Additional nucleic acid testing is necessary to confirm active infection. More research is needed to determine the underlying causes of HCV antibody positivity by injection use

HIV, Drug Use, Sexual Risk (5 works) · Medicine (5 works) · Hepatitis C virus research (4 works) · Psychiatry (4 works) · Hepatitis C (3 works) · Internal Medicine (3 works) · Nursing (3 works) · Psychology (3 works) · Syringe (3 works) · Drug (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae